State of Hypertension Management in the United States: Confluence of Risk Factors and the Prevalence of Resistant Hypertension
Population
Patients with hypertension in the United States
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Persistent gaps in US blood pressure control signal need for systemic strategies; leaves open which interventions best curb rising resistant hypertension.
Key Points
- Analyze current hypertension control rates in the United States, identify barriers to target blood pressure achievement, and evaluate interventions for resistant hypertension.
- Narrative review evaluating national epidemiological data on blood pressure control rates relative to Healthy People 2000 and 2010 goals.
- Synthesized evidence on contributing clinical risk factors, provider prescribing patterns, and patient adherence barriers.
- Assessed health system interventions, such as Veterans Administration initiatives, and emerging pharmacotherapies designed for resistant hypertension.
- Blood pressure control rates in the United States fail to meet national benchmarks despite improved awareness, driven by an aging demographic, kidney disease, obesity, high sodium intake, therapeutic inertia, and poor medication adherence.
- Resistant hypertension, defined as uncontrolled blood pressure despite adherence to a three-drug regimen including a diuretic, is projected to rise as the population ages.
- Structured health system protocols and novel targeted drug therapies demonstrate efficacy in lowering resistant hypertension rates and improving blood pressure goal attainment.
Structured PICO
P
Population
Patients with hypertension in the United States
Systemic efforts and new medications are needed to address the growing prevalence of resistant hypertension and improve overall blood pressure control in the US.
Cite This Study
Sarafidis et al. (2008) studied this question.